Revenue: The sum of all revenue fields included for a company's operating activities.
Rhythm Pharmaceuticals, Inc. (RYTM) had Revenue of $130.13M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$130.13M |
$-264.57M |
|
$13.37M |
|
$116.76M |
|
$395.63M |
|
$-265.50M |
|
$5.25M |
|
$-260.26M |
|
$-260.26M |
|
$-260.60M |
|
$-260.60M |
|
$-260.60M |
|
$-260.60M |
|
$-265.50M |
|
$-263.94M |
|
60.99M |
|
60.99M |
|
$-4.34 |
|
$-4.34 |
|
| Balance Sheet Financials | |
$374.20M |
|
$0.63M |
|
$18.07M |
|
$392.27M |
|
$115.52M |
|
-- |
|
$112.21M |
|
$227.72M |
|
$21.73M |
|
$158.38M |
|
$164.55M |
|
62.39M |
|
| Cash Flow Statement Financials | |
$-113.88M |
|
$-48.17M |
|
$191.24M |
|
$60.41M |
|
$89.60M |
|
$29.19M |
|
$39.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
89.73% |
|
-204.04% |
|
-204.04% |
|
-202.83% |
|
-200.00% |
|
-203.32% |
|
$-154.38M |
|
-- |
|
-- |
|
-- |
|
0.33 |
|
0.71 |
|
7.03 |
|
51.93 |
|
-1199.32% |
|
-164.55% |
|
-66.43% |
|
-158.37% |
|
$2.64 |
|
$-2.53 |
|
$-1.87 |
|